| Sarah Conner, MS, CCC-SLP | |
|
1061 Michigan Ave Ste B, Muskegon, MI 49441-1883 | |
| (231) 747-7539 | |
| Not Available |
| Full Name | Sarah Conner |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1061 Michigan Ave Ste B, Muskegon, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841681590 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 7101003438 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Conner, MS, CCC-SLP 1061 Michigan Ave Ste B, Muskegon, MI 49441-1883 Ph: (231) 747-7539 | Sarah Conner, MS, CCC-SLP 1061 Michigan Ave Ste B, Muskegon, MI 49441-1883 Ph: (231) 747-7539 |
News Archive
JHP Pharmaceuticals' sterile manufacturing site based in Rochester, Michigan completed a successful GMP (Good Manufacturing Practices)/Pre Approval Audit by the U.S. Food and Drug Administration (FDA) drug division (CDER).
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
Republican Gov. Jan Brewer of Arizona said Thursday that despite opposition from legislators from within her own party, she's seeking money from the federal government to implement a key part of the health care overhaul she opposes in order to prepare her state in case the law is upheld.
Gilead Sciences, Inc. announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain commercially available protease inhibitors, including atazanavir and darunavir, in order to enable once-daily dosing.
› Verified 3 days ago
Julia Tans, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1910 E Apple Ave Ste H, Muskegon, MI 49442 Phone: 231-333-9148 | |
Mrs. Lea Dawn Norbotten, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1080 E Sternberg Rd, Muskegon, MI 49444 Phone: 231-799-2200 Fax: 231-799-2201 | |
Swan Marie Reddy, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 376 E Apple Ave, Muskegon, MI 49442 Phone: 231-724-1111 Fax: 231-724-4188 | |
Michelle Clockman, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 695 Mitzi St, Muskegon, MI 49445 Phone: 231-744-1641 | |
Amy D Ballot, MA,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 635 W Summit Ave, Muskegon, MI 49441 Phone: 888-488-9030 | |
Ms. Kelly Rimbey, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 376 E Apple Ave, Muskegon, MI 49442 Phone: 231-724-1111 Fax: 231-724-1300 | |
Sara Nekic, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 695 Mitzi St, Muskegon, MI 49445 Phone: 231-744-0520 |